The mega-cap pharma company I work for is switching from DocuSign to Adobe Sign. In the announcement, they note "over 50% cost savings compared to DocuSign." $ADBE
Thoughts on biotech supply chain/Why
@PythiaR
should buy every $TMO dip
Background: Have worked in large academic research labs since undergrad days (circa 2011). Recently moved and started work at a mega-cap pharmaceutical company.
For all you $DHR longs, this is a Beckman Coulter Optima Ultracentrifuge.
Easily the most dangerous equipment in the lab.
By spinning a 50lb shaft head at 70,000rpm for 2hrs, I'm able to separate viruses from the human cells I grow them in.
People were very interested in the Beckman Coulter ultracentrifuge I posted last Friday. Beckman Coulter is a subsidiary of Danaher $DHR.
So, as they say, time for a thread...
My watch list for potential December tax loss selling:
DG, MKTX, MKC, AAP, CROX, TMO, DHR, KO, PEP, KDP, CLX
Any others?
Please, no banks, utilities, or shit co's.
An example of this: last week I made some virus.
In order to quantify how much virus I made, I put $TMO buffers into $TMO tubes and run them through multiple $TMO machines.
@diglamb
@LSValue
@RMarshSPark
@rsandler21969
In my experience as a scientist, no.
$DHR is important for my job, mainly through Beckman, but I really cannot express how absolutely ***critical*** $TMO is for my day-to-day experimentation. They are ingrained in basically every part of the lab.
Examples of $DHR consumables:
Leica microtome blades
Beckman ultracentrifuge tubes
Cytiva MW spin columns
Pall filters
The first two are completely 'locked in' because of the specific machines.
Cc
@MDBBolsa
@CJ0pp3l
@JerryCap
$TMO inventory update:
I will add that pipette tips were one of the truly awful COVID supply crunch items, so this is probably just bullwhip working through.
In honor of $TMO earnings day, here is a pic of my nearest common supplies shelf at 4C. Common supplies are stocked twice daily by the Operations team.
Everything *not* covered in red is a Thermo product.
In honor of $TMO earnings day, here is a pic of my nearest common supplies -20C. Common supplies are stocked daily by Operations team.
It's literally all Thermo products.
$DFS with a 17% dividend increase ($0.70 per quarter) and announces a buyback program for ~10% of their shares at today's closing price.
Seriously don't know why it trades so cheap, but I'll gladly continue holding.
Sorry $DHR and $SOAGY longs: Cytiva and Sartorius are our first choice for MW filters but both are backordered until July.
So we stocked up on Thermo $TMO ones.
Yesterday, I attended a presentation by Thermo $TMO on their latest CGT products. It was concentrated on cell therapies.
Unfortunate because I'm mainly gene therapies, but I still had fun.
Some impressions and thoughts:
A very critical sentence in the latest obesity treatment paper that everyone seems to be glossing over. $NVO $LLY
It's ridiculous that these patients weren't followed by DEXA (or other body composition measure).
@diglamb
@LSValue
@RMarshSPark
@rsandler21969
In my experience as a scientist, no.
$DHR is important for my job, mainly through Beckman, but I really cannot express how absolutely ***critical*** $TMO is for my day-to-day experimentation. They are ingrained in basically every part of the lab.
A race has begun to prove the potential of CAR-T cell therapies in autoimmune diseases, with multiple agents now in clinical trials for lupus - find out more in this news article in the November issue
Since I mentioned it this morning, here are the 24 companies whose full catalogs are fully within our ordering system. Makes it exponentially easier. I'd estimate that 97%+ of my personal order are through these companies.
I've commented several times before about how $TMO has the best sales team, but to give you an idea, the two reps today are PhDs from UVA and Open University. They are trained scientists, not salespersons.
The tradition continues: in honor of $TMO earnings, here is a pic of a common supply 4C. Common supplies are stocked daily by Operations. This one is up on the 4th floor (I work on the 2nd).
Exact for a specific RPMI made by Sigma (blue box), it's literally all Thermo.
In honor of $TMO earnings day, here is a pic of a nearby common supplies at RT. Common supplies are stocked daily by Operations team.
It's literally all Thermo products.
@trekonomics
There is absolutely a timeline where germophobe Trump takes over, gives total control and resources to the medical experts, we look like EU/South Korea, and Trump **landslides** Biden in November.
@PythiaR
I guess if I had to summarize in single tweet:
Whenever we need something in lab, I first look on $TMO because 1) they've aggregated so much they usually have it 2) if not A+ quality it's good enough 3) decent to downright good pricing and 4) sales team that will work with us
One of the main takeaways from the GLP-1 story is how much we've been 'shooting ourselves in the foot' by allowing the obesity epidemic to rampage, and rather than doing the, granted hard, structural & cultural work to alleviate it, we're going to allow pharma companies to profit
I just significantly reduced one of my 'never sell' positions. The thesis was working **too well** and I don't know how to feel selling one of my favorite positions.
@DogFundAdvisors
@CJOppel
@BillBrewsterTBB
@PythiaR
@JerryCap
Some explanation and real time thoughts:
These are actually tubes that go in the rotor head. As you can imagine, you can't just place any old thing at 70K rpm. These are special tubes formatted for specific rotors (see label).
Each tube can only be used once. Can someone say recurring revenue?
The thing that no one really admits: if you want to fix the cost of healthcare in the US, everyone needs to take a cut:
Physicians, insurance, hospitals, and pharma should all make less, most administrators should be fired, advertising banned, lawyers go bye bye, etc
Big
#AI
discovery: a new structural class of antibiotics (the last one took 38 years) with multiple compounds effective vs methicillin-resistant Staph aureus, without toxicity
@Nature
Our self-propelled CAR T cells expressing synthetic “velocity” receptors infiltrate pancreatic tumors like its butter (bottom). Control CAR T cells can’t (top).
Game over.
Works in any solid tumor; can transform any CAR T of your choice into a Ferrari.
How could I possibly forget $HSY??
Seriously, as an individual investor, that's a true coffee-can, buy-and-forget name.
I'm buying some in my Roth on Monday. No DD. Ozempic has nothing on generations of Halloweens and Valentine's Days.
Quick, off-top short list for this:
-CAR-Ts w/ solid tumor infiltration
-True allogeneic or universal cells
-CARs in other cell types beyond T
-Advanced tissue engraftment or encapsulation
-Functional organoids
-Next gen stem cells, either ES or iPSC
-Next gen engineered viruses
@sinstockpapi
@Larryjamieson_
@Borlaug_
@peter_mantas
I think the average person underestimates the right tail for gene & cell therapies. One can imagine a couple luck breaks & hard work breakthroughs and 'suddenly' we're grandma isn't taking pills anymore but rather a biological entity of some type.
Our Charles River $CRL rep just emailed me about two new and very interesting mouse strains.
My experimental design neurons are already firing...
Cc
@peter_mantas
@hkuppy
The public health response to COVID was exponentially stronger than the 2017/18 influenza, yet excess deaths the same, and we're only five months into COVID.
No one is being hysterical.
I enjoyed the GLP-1s Odd Lots episode
@TheStalwart
@tracyalloway
w/
@Citrini7
However, I'm disappointed that there wasn't a question about body composition.
My fav 2nd order effect: new clothes. Imagine millions of Subway Jareds. Long $LEVI & $LULU??
A very critical sentence in the latest obesity treatment paper that everyone seems to be glossing over. $NVO $LLY
It's ridiculous that these patients weren't followed by DEXA (or other body composition measure).
An under-discussed tail risk for Novo $NVO and Lilly $LLY is a successful FGF21 therapeutic, which causes both weight loss AND reduces alcohol consumption. Multiple companies have developed and are developing an FGF21 product.
@healingspaces
@brglicker
@PeterAttiaMD
This dude needs a heart transplant.
An "experimental" vaccine and hypothetical risk of "cancer" are literally the least of his problems.
Today's lunch brought to me by Corning $GLW SG&A.
Given how much I use their products, always have to remind myself that Life Sciences is their smallest division.
Wowza!
Losing 20lbs with GLP-1 agonist (semaglutide)
averts heart attacks/strokes
and
saves lives
(in patients who are overweight, without diabetes but with pre-existing atherosclerotic cardiovascular disease)
The GLP-1s are an amazing breakthrough and have legitimate uses, but I continue to believe that investors are drastically underpricing:
-the risk of negative side effects (e.g. lean muscle loss, etc.)
-the risk of insurance companies & governments limiting pricing
Also, this is an older model. We have newer models, I'm just lazy and didn't feel like walking over.
Newer model has touchscreen and more precise controls. Also probably safety improvements that I'm not aware of.
The microbe team near us just received a brand new Beckman benchtop centrifuge. Just as with the ultracentrifuges, they've ditched buttons for touchscreens. $DHR
This same thing has been said generation after generation for all of human history, so I wonder who is the one that lacks critical reasoning skills and emotional resilience.
@PythiaR
Left pipette tip from $TMO, right from $MTD.
No different except right tip has "LTS" imprinted on it (MTD trademark) and costs ~30% more, even after academic discount.
@compound248
Hey Compound, biomedical scientist here. The strain of mice they used is designed to have high mortality when exposed to CoV-2 and would not translate to humans. Whether or not they should be doing this is a separate question.
@sinstockpapi
@Larryjamieson_
@Borlaug_
@peter_mantas
I think the average person underestimates the right tail for gene & cell therapies. One can imagine a couple luck breaks & hard work breakthroughs and 'suddenly' we're grandma isn't taking pills anymore but rather a biological entity of some type.
On this note, I've wondered how much of the life science slowdown is just bullwhip.
It's wild the amount of stuff we find squirrelled away from during the supply chain crisis.
Every time we clean the lab/someone leaves, we find more useful stuff that we put back in inventory.